HCR 553 Module 3 Quality Management Plan Example

Course	HCR 553 Quality Assurance and Clinical Research
Module	Module 3
Paper type	Quality management plan
Length	About 652 words, 5 pages
Format	APA 7 student paper
School	Arizona State University
Program	MS in Clinical Research Management
Updated	October 2026

Free sample paper for HCR 553 Module 3

Quality Management Plan: Critical-to-Quality Factors in a Phase 3 Knee Osteoarthritis Pain Trial

Student Name

MS in Clinical Research Management, Arizona State University

HCR 553: Quality Assurance and Clinical Research

Instructor Name

Month Day, Year

What this page is doingThe title follows the form of a sponsor's plan document and names the protocol it covers.

Quality Management Plan: Critical-to-Quality Factors in a Phase 3 Knee Osteoarthritis Pain Trial

1. Purpose and Scope

This quality management plan (QMP) describes how the sponsor will protect participant safety and the reliability of results in Study OA-301, a 24-week, randomized, double-blind, placebo-controlled Phase 3 trial of a once-weekly subcutaneous injection for moderate to severe knee osteoarthritis pain, enrolling 600 participants at 40 sites. It follows the risk-based, quality-by-design approach in current good clinical practice and clinical study design guidelines, which ask sponsors to identify the factors critical to quality before the study starts and to focus effort on them (U.S. Food and Drug Administration, 2022; U.S. Food and Drug Administration, 2025).

2. Critical-to-Quality Factors

Critical-to-quality factors are the attributes of a study whose failure would harm participants or make the results unreliable.

Factor	Why it is critical
Eligibility	Radiographic severity and baseline pain must be right, or the population will not match the label
Primary endpoint	Weekly pain scores on an electronic diary drive the efficacy conclusion
Blinding	Injections must look identical; unblinding would bias a subjective endpoint
Rescue medication	Unrecorded analgesic use would mask the drug's effect
Investigational product handling	Refrigerated product must stay within temperature limits
Safety events of special interest	Rapidly worsening joint damage and injection-site reactions must be detected and adjudicated

What this page is doingEach factor is tied to either participant safety or result reliability, the two outcomes a quality plan exists to protect.

3. Risk Assessment

Factor	Risk	Likelihood	Impact	Priority
Eligibility	Sites enroll participants whose X-ray grade does not qualify	Medium	High	High
Primary endpoint	Low diary compliance creates missing data	High	High	High
Blinding	Different syringe appearance at a site	Low	High	Medium
Rescue medication	Participants take unrecorded analgesics	Medium	High	High
Product handling	Refrigerator excursions not reported	Medium	Medium	Medium
Safety events	Joint events not reported promptly	Low	High	High

4. Controls and Monitoring

Eligibility: central reading of knee X-rays before randomization, so no participant is randomized on a site reading alone. Primary endpoint: diary reminders, weekly compliance reports to sites and a call when a participant misses two consecutive days. Blinding: unblinded pharmacists prepare doses in identical syringes, and blinding is tested in an end-of-study questionnaire. Rescue medication: rescue analgesics dispensed and counted at each visit, with diary questions on any other pain medicine. Product handling: temperature loggers with automatic alerts and a 24-hour reporting requirement. Safety events: protocol-specified imaging triggers, mandatory reporting within 24 hours and blinded adjudication by an independent committee.

Monitoring is risk-based. Central monitoring reviews diary compliance, rescue use, enrollment patterns and data anomalies weekly across sites, and on-site visits concentrate on sites whose central indicators signal risk, consistent with FDA guidance on risk-based monitoring (U.S. Food and Drug Administration, 2023).

5. Quality Tolerance Limits

Parameter	Limit that triggers review
Participants randomized in error	More than 2% of randomized participants
Missing primary endpoint data at week 12	More than 15% of participants
Rescue medication use above protocol maximum	More than 10% of participant-weeks
Unreported temperature excursions	Any at a site
Delayed reporting of a safety event of special interest	Any report later than 24 hours

6. Issue Management and Escalation

Deviations are logged in the clinical trial management system, classified as important or not and reviewed weekly. A breach of a quality tolerance limit is escalated to the study's quality review team within five business days, which determines the root cause and a corrective and preventive action. Breaches that affect safety or the primary endpoint are reported to sponsor leadership and described in the clinical study report.

7. Roles and Review

The clinical operations lead owns the plan. Data management, medical monitoring, biostatistics and quality assurance each own their controls. The plan is reviewed after the first 100 participants complete week 4 and at each protocol amendment.

8. Conclusion

The plan concentrates effort on the six factors whose failure would harm participants or weaken the trial's conclusion. Defining limits in advance turns quality from a judgment made at the end of a study into a set of signals watched throughout it.

References

U.S. Food and Drug Administration. (2022). E8(R1) general considerations for clinical studies [Guidance for industry]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e8r1-general-considerations-clinical-studies

U.S. Food and Drug Administration. (2023). A risk-based approach to monitoring of clinical investigations: Questions and answers [Guidance for industry]. https://www.fda.gov/media/121479/download

U.S. Food and Drug Administration. (2025). E6(R3) good clinical practice (GCP) [Guidance for industry]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r3-good-clinical-practice-gcp

HCR 553 Module 3 instructions, in plain terms

Major Assignment 1 is due in Week 3 of HCR 553, the week on quality management plans, and its 150 points tie it with the pulled-from-market assignment as the heaviest graded work in the course. The syllabus asks you to identify critical factors of clinical trial protocols from the perspective of quality execution and risk management. In current guidance language these are critical-to-quality factors: the parts of a study whose failure would harm participants or make the results unreliable. The assignment is easiest to do well when you work from one protocol, real or realistic, so that every factor, risk and control is specific. A plan that follows the shape of an actual sponsor quality management plan, with factors, risk assessment, controls, monitoring, tolerance limits and escalation, shows the reader you understand how quality is managed in practice. APA style is the course default.

Inside the HCR 553 Module 3 example

The plan is written as a sponsor document with numbered sections. Section 1 states what the plan covers, which study, and which guidance shapes it. Section 2 names six critical-to-quality factors and says in a table why each matters, and Section 3 scores each risk for likelihood and impact. Section 4 assigns controls factor by factor and explains how central and on-site monitoring divide the work. Section 5 sets quality tolerance limits in a table, and Section 6 explains how deviations and breaches are escalated and corrected. Roles and review timing come next, and a short conclusion explains why limits set in advance matter.

HCR 553 Module 3 rubric: what earns full marks

The quality management plan is worth 150 points on its Canvas rubric. A strong plan identifies critical factors that are truly critical for the chosen protocol, explains why each matters to safety or reliability, assesses risk with a consistent method, matches each risk to a specific control and monitoring approach, sets measurable tolerance limits and describes escalation and corrective action with named roles. Points are lost when factors are generic (good documentation, trained staff) rather than protocol-specific, when risks are listed without controls, when monitoring is described only as site visits and when no measurable limits are set. Graders in this course also value a plan that reads like an operational document, since a QMP is used by a study team, not only read by an instructor.

HCR 553 Module 3 help from the desk

Choose one protocol and read its endpoints, eligibility and safety sections first; critical factors come from there. Ask of each candidate factor: would its failure harm participants or change the answer? Rate risks with the same scale throughout. Give every risk a control and a way to monitor it. Set tolerance limits as numbers. Name who owns each piece. Use current guidance on quality by design and risk-based monitoring. If you need a realistic protocol to build on, the desk can suggest a public trial summary. Treat the plan as a living document: say when it will be reviewed and what would trigger an update, such as a protocol amendment or a tolerance limit breach.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official Arizona State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.

More HCR 553 and MS in Clinical Research Management sample papers

HCR 553 Module 3 questions, answered

Where can I find a free HCR 553 Module 3 sample paper?

The complete quality management plan for a Phase 3 knee osteoarthritis trial is on this page.

What are critical-to-quality factors in a clinical trial?

Study attributes whose failure would harm participants or make results unreliable, such as eligibility, the primary endpoint and blinding.

What is a quality tolerance limit?

A predefined threshold, such as a maximum rate of missing primary data, that triggers review when crossed.

What does a quality management plan include?

Critical factors, risk assessment, controls, monitoring, tolerance limits, issue escalation and roles.

How much is the HCR 553 quality management plan worth?

150 points, one of the two major assignments in the course.

HCR 553 Module 3 Major Assignment 1: Quality Management Plan Example